These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32014926)

  • 41. Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells.
    Pogash TJ; El-Bayoumy K; Amin S; Gowda K; de Cicco RL; Barton M; Su Y; Russo IH; Himmelberger JA; Slifker M; Manni A; Russo J
    In Vitro Cell Dev Biol Anim; 2015 Feb; 51(2):121-7. PubMed ID: 25413005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination therapy of calcitriol inhibits the proliferation of breast cancer cells: new concept of nonclassical function of calcitriol.
    Aljunidee KA; Bardaweel SK
    Horm Mol Biol Clin Investig; 2021 Nov; 43(2):199-205. PubMed ID: 34768317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of VDR-responsive gene signatures in breast cancer cells.
    Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
    Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.
    Gschwantler-Kaulich D; Weingartshofer S; Grunt TW; Mairhofer M; Tan Y; Gamper J; Singer CF
    PLoS One; 2017; 12(9):e0185566. PubMed ID: 28945801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and Biological Activity of Diastereomeric and Geometric Analogs of Calcipotriol, PRI-2202 and PRI-2205, Against Human HL-60 Leukemia and MCF-7 Breast Cancer Cells.
    Milczarek M; Chodyński M; Filip-Psurska B; Martowicz A; Krupa M; Krajewski K; Kutner A; Wietrzyk J
    Cancers (Basel); 2013 Oct; 5(4):1355-78. PubMed ID: 24202449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential response of lung cancer cell lines to vitamin D derivatives depending on EGFR, KRAS, p53 mutation status and VDR polymorphism.
    Maj E; Trynda J; Maj B; Gębura K; Bogunia-Kubik K; Chodyński M; Kutner A; Wietrzyk J
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105431. PubMed ID: 31326626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
    Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
    Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients.
    Zhang X; Hofmann S; Rack B; Harbeck N; Jeschke U; Sixou S
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin D and prevention of breast cancer.
    Welsh J
    Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells.
    Alimirah F; Peng X; Gupta A; Yuan L; Welsh J; Cleary M; Mehta RG
    Exp Cell Res; 2016 Nov; 349(1):15-22. PubMed ID: 27693451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.
    Ghosh S; Pal A; Ray M
    Biomed Pharmacother; 2019 Jun; 114():108855. PubMed ID: 31003140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selenium Nanoparticles Induce the Chemo-Sensitivity of Fluorouracil Nanoparticles in Breast and Colon Cancer Cells.
    Abd-Rabou AA; Shalby AB; Ahmed HH
    Biol Trace Elem Res; 2019 Jan; 187(1):80-91. PubMed ID: 29748931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of a vitamin D3-resistant MCF-7 cell line.
    Narvaez CJ; Vanweelden K; Byrne I; Welsh J
    Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.
    Al Safarjalani ON; Rais R; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1449-55. PubMed ID: 22373605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
    El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
    Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glaucarubulone glucoside from Castela macrophylla suppresses MCF-7 breast cancer cell growth and attenuates benzo[a]pyrene-mediated CYP1A gene induction.
    Badal SAM; Asuncion Valenzuela MM; Zylstra D; Huang G; Vendantam P; Francis S; Quitugua A; Amis LH; Davis W; Tzeng TJ; Jacobs H; Gangemi DJ; Raner G; Rowland L; Wooten J; Campbell P; Brantley E; Delgoda R
    J Appl Toxicol; 2017 Jul; 37(7):873-883. PubMed ID: 28138972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors.
    Zinser GM; Tribble E; Valrance M; Urben CM; Knutson JC; Mazess RB; Strugnell SA; Welsh J
    Anticancer Res; 2005; 25(1A):235-41. PubMed ID: 15816543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
    Yuan J; Lv H; Peng B; Wang C; Yu Y; He Z
    Cancer Chemother Pharmacol; 2009 May; 63(6):1103-10. PubMed ID: 18820913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.